Loading...

ALKEM Alkem Laboratories Ltd Earnings Reports Announcement

lkm

LKM

Alkem Laboratories Ltd

(ALKEM)

2025 Announcement

Senior management resignation

Unclaimed Dividend

Analyst / Institutional Mee...

Senior Management Appointment

Analyst & Investor Meetings

Sustainability Report

Analyst / Investor Meeting

Regulatory Inspection

Earnings Guidance and Discu...

GST order / tax dispute

Unaudited Results

Analyst / Institutional Inv...

Earnings Call Audio

Regulatory Compliance

Q2 FY26 results

Unaudited results

Unaudited Results

EU GMP Inspection

GST Penalty Order

Strategic Collaboration

Strategic Collaboration

Investor Conference Call

Investor Conference Call

Board Meeting Notice

GST Demand Order

Business Transfer Agreement

Management Change

GST Order Received

GST Regulatory Order

Investor Meetings

Investor Meeting

Investor Meetings

Meeting Cancellation

Investor Meetings

Investor Meeting

Investor Meetings

Earnings Call Transcript

Earnings Call Update

Q1 FY26 Results

Investor Meeting

Q1FY26 Conference Call

Regulatory Order

AGM Notice Dispatch

Reclassification Approval

Postal Ballot Notice

AGM Announcement

Dividend Notification

Facility Sale Completed

New Independent Director

GST Demand Order

Postal Ballot Notice

Investor Meeting

Investor Meeting

Investor Meetings

Regulatory Order

Investor Meeting

Q4 FY2025 Earnings

Earnings Call Recording

Secretarial Compliance Report

Q4 FY25 Results

Secretarial Auditor Appoint...

Director Appointments

Investor Meeting

Cyber Security Incident

Acquisition Completed

Acquisition Completed

Management Change

GST Order Received

Acquisition Update

Investor Meeting

Investor Presentation

Investor Meetings

Alkem Acquisition Update

FDA Inspection Result

Management Change

Investor Meetings

Regulatory Order

GST Demand Order

Management Change

Regulatory Order

GST Demand Order

GST Demand Order

GST Demand Orders

Trust Deed Amendment

Investor Meeting

GST Demand Order

Investor Meetings

GST Regulatory Order

Earnings Call Transcript

Investor Meeting Scheduled

Earnings Call Update

Interim Dividend Notice

Acquisition Announcement

Acquisition Announcement

Q3FY25 Earnings Report

Kojiglo Serum Launch

GST Demand Order

Investor Meetings

GST Order Received

Q3FY25 Call Invitation

Equity Allotment Update

Facility Sale Announcement

GST Demand Order

Name Change Announcement

GST Order Received

Regulatory Order Received

Tax Orders Received

Dividend Notice

Equity Investment

Tax Regulatory Order

Investor Meetings

Business Transfer Approval

Investor Meeting Schedule

Investor Meeting Scheduled

Q2 FY25 Earnings Update

Earnings Call Recording

Q2 & H1 FY25 Results

Regulatory Notice

Investor Meetings

Management Change

Management Change

Licensing Agreement Signed

Management Change

Quality Claims Denied

Regulatory Orders

Regulatory Order

Investor Meeting

Investor Meeting

New Subsidiary Formation

Investor Meeting

Investor Meeting Scheduled

Postal Ballot Notice

GST Demand Order

Investor Meeting

GST Penalty Order

GST Demand Order

Investor Meetings

Investor Meetings

Investor Meetings

Investor Meetings

Q1 FY2025 Earnings Call

Cut-off Date for Postal Ballot

Financial Results

Director Appointment

Conference Call Intimation

Order-In-Appeal for Service...

Newspaper Advertisement

Regulatory Order

Management Change

GST Order-In-Appeal

Incorporation of Subsidiary

Newspaper Advertisement

Management Change

Management change

FDA Inspection Closure

Resignation of Director

Reclassification Request Re...

Regulatory Order

Investment Announcement

Transcript Provided

Meeting Intimation

Earnings Conference Call

Compliance Report

Financial Results Announcement

Appointment of Auditor

Directors Re-appointment

Conference Call

GST Demand Order Received

GST Demand Order

Reclassification Application

Tax Demand Order

Tax Dispute Response

Certificate Submission

Compliance Certificate

Annual General Meeting Outcome

Regulatory Order

Incorporation of Subsidiary

Meeting Schedule

Meeting Intimation

Meeting Schedule

Investor Meetings

Meeting Intimation

Postal Ballot Notice

Regulatory Penalty Imposed

FDA Inspection Closure

Tax Allegations

Earnings Call Transcript

Earnings Conference Call Re...

Earnings Conference Call - ...

Dividend Announcement

Reclassification Request

Postal Ballot Cut-Off Date

Financial Results Announcement

Management Changes

Q3FY24 Conference Call

Conference Call

Reclassification Request

Cyber Security Incident

Management Change

Management Appointment

Analyst Meeting

Analyst/ Investor Meeting

Meeting Announcement

Newspaper Advertisement

Analyst/Investor Meeting

Investor Meeting

Analyst/Investor Meeting

Analyst/Investor Meeting

Investor Meeting

Management Change

Inspection Observations

Senior Management Appointment

Analyst/Investor Meet - Int...

Analyst/Investor Meetings

Appointment of Senior Manag...

Meeting Announcement

Meeting Schedule

Analyst/Investor Meeting

Management Appointment

Meeting Intimation

Analyst/Investor Meeting

Meeting Schedule

Meet Announcement

Investor Conferences

Analyst/ Investor Meeting -...

Financial Results

Cut-Off Date For Postal Ballot

Amendment Approval & Financ...

Meeting Schedule

Conference Call for Q2FY24

Investor Conferences

Schedule Announcement

Management Appointment

Meeting Schedule

Dividend Claims Advertisement

Newspaper Advertisement

Analyst/Investor Meeting

Schedule of Meetings

Schedule Announcement

Investor Meeting

Amendment to Articles of As...

Analyst/Investor Meeting

Analyst/Investor Meetings

Conference Call Transcript

Analyst/Investor Meetings

Earnings Guidance

Financial Statements

Merger of Equals

Financial Statements

Analyst Meetings

Analyst/Investor Meetings

Analyst/Investor Meet

Analyst/Investor Meeting

Analyst/Investor Meeting

Analyst/Investor Meeting

Analyst/Investor Meetings

Analyst/Investor Meeting

Management Changes

Management Changes

Dividend Recommendation

Financial Statements

Financial Results Conferenc...

External Links:

Data:

Alkem reports Q2 FY26 standalone and consolidated revenue ₹40,010 million (↑17.2% YoY), EBITDA ₹9,208 million (↑22.3%), and net profit ₹7,651 million (↑11.1%), with strong growth in India and international markets.

AI Assistant

Alkem Laboratories Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.